Novartis Sues FDA For OK'ing Generic Herpes Drug
Novartis Pharmaceuticals Corp. has accused the U.S. Food and Drug Administration of improperly granting Watson Laboratories Inc.'s abbreviated new drug application for a generic version of herpes treatment drug Famvir....To view the full article, register now.
Already a subscriber? Click here to view full article